Table 1.
aFirst event defined according to the disease-free survival criteria (i.e., local relapse, regional relapse, distant relapse, contralateral breast cancer, death of any cause).
Abbreviations: FEC, fluorouracil, epirubicin, and cyclophosphamide; FEC-D, fluorouracil, epirubicin, and cyclophosphamide followed by docetaxel.